Udi # - in the absence of reported part number, udi could not be provided.Exemption number (b)(4).There was no reported device malfunction and the product was not returned as the scaffold remains in the anatomy.A review of the lot history record and complaint history of the reported lot could not be conducted because the part and lot number were not provided.Based on the case information a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effect of dissection, as listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use is a known adverse event associated with the use of a coronary scaffold in native coronary arteries.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.Attached, article title: "acute angiographic and intermediate-term clinical results of patients with non-left main coronary bifurcation lesions treated with bvs by jailed semi-inflated balloon technique and provisional side-branch stenting strategy." the absorb device is currently not commercially available in the u.S; however, it is similar to a device sold in the us.
|